← Back to headlines

Eli Lilly's Gene-Editing Therapy Shows Promise in Preventing Heart Attacks
Eli Lilly's new gene-editing therapy has demonstrated significant potential in preventing heart attacks by reducing LDL cholesterol levels by 62% in trials.
27 May, 02:14 — 27 May, 02:14
Sources
Showing 1 of 1 sources



